Zhengye Biotechnology Holding Ltd completed its IPO on January 8, 2025, selling 1,500,000 ordinary shares at $4.00 per share, which began trading on Nasdaq under the ticker symbol 'ZYBT'. This is a significant event as it marks the company's entry into the public market.